Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents
- PMID: 1720497
- DOI: 10.1002/mpo.2950190606
Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents
Abstract
From September 1984 to December 1989, 38 patients of pediatric age with localized bone sarcomas received intraoperative radiotherapy (IORT) as part of a multidisciplinary treatment program. The age ranged from 6 to 21 years. The tumor histologies were 22 osteosarcomas and 16 Ewing's sarcomas. Thirty-four had initial primary disease (90%) and 4 were treated for local recurrence (10%). IORT was used on 32 untreated patients and in 6 previously treated with external beam radiotherapy (EBR). The IORT field included the surgically exposed tumor bed area. Single radiation doses ranging from 10 to 20 Gy were delivered, using 6-20 MeV electron beams. The median follow-up time for the entire group is 25 months (2-65+ months). The projected 5-year disease-free and overall survival rates are 65% and 69%, respectively. One patient developed a local recurrence in each histological group: one chondroblastic osteosarcoma and one cervical Ewing's sarcoma. Six patients died from metastatic progression: 3 initially recurrent tumors and three primary disease cases. Severe neuropathy and soft tissue necrosis were seen in some patients as IORT related complications. IORT is a feasible technique to be integrated in multidisciplinary programs that may promote local control in pediatric and adolescent patients with bone sarcomas. Peripheral nerves are dose-limiting tissue structures for IORT.
Similar articles
-
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35. doi: 10.1016/s0360-3016(98)00191-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9747829 Clinical Trial.
-
The value of adjuvant chemotherapy in the management of sarcomas in children.Cancer. 1985 May 1;55(9 Suppl):2184-97. doi: 10.1002/1097-0142(19850501)55:9+<2184::aid-cncr2820551422>3.0.co;2-n. Cancer. 1985. PMID: 3884137 Review.
-
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.Acta Oncol. 1998;37(4):375-8. doi: 10.1080/028418698430601. Acta Oncol. 1998. PMID: 9743460
-
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30. doi: 10.1016/0360-3016(95)00016-r. Int J Radiat Oncol Biol Phys. 1995. PMID: 7607966 Clinical Trial.
-
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.J Clin Oncol. 2001 Feb 1;19(3):870-80. doi: 10.1200/JCO.2001.19.3.870. J Clin Oncol. 2001. PMID: 11157041 Review.
Cited by
-
Intraoperative radiotherapy in the treatment of neuroblastoma: report of a pilot study.Ann Surg Oncol. 1995 Jul;2(4):343-50. doi: 10.1007/BF02307068. Ann Surg Oncol. 1995. PMID: 7552625
-
Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience.Radiat Oncol. 2017 Aug 15;12(1):130. doi: 10.1186/s13014-017-0860-6. Radiat Oncol. 2017. PMID: 28806981 Free PMC article.
-
Intraoperative radiation therapy for advanced neuroblastoma: the problem of securing the IORT field.Pediatr Surg Int. 2007 Dec;23(12):1203-7. doi: 10.1007/s00383-007-2065-9. Epub 2007 Oct 30. Pediatr Surg Int. 2007. PMID: 17968560
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources